AU2001241566A1 - Nucleation and crystallization of polymers - Google Patents

Nucleation and crystallization of polymers

Info

Publication number
AU2001241566A1
AU2001241566A1 AU2001241566A AU4156601A AU2001241566A1 AU 2001241566 A1 AU2001241566 A1 AU 2001241566A1 AU 2001241566 A AU2001241566 A AU 2001241566A AU 4156601 A AU4156601 A AU 4156601A AU 2001241566 A1 AU2001241566 A1 AU 2001241566A1
Authority
AU
Australia
Prior art keywords
nucleation
crystallization
polymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001241566A
Inventor
Allan S Myerson
Karthigeyan Nagarajan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001241566A1 publication Critical patent/AU2001241566A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/10—Analysis or design of chemical reactions, syntheses or processes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C10/00—Computational theoretical chemistry, i.e. ICT specially adapted for theoretical aspects of quantum chemistry, molecular mechanics, molecular dynamics or the like

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Computing Systems (AREA)
  • Theoretical Computer Science (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AU2001241566A 2000-02-17 2001-02-17 Nucleation and crystallization of polymers Abandoned AU2001241566A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50747500A 2000-02-17 2000-02-17
US09507475 2000-02-17
PCT/US2001/005279 WO2001061345A1 (en) 2000-02-17 2001-02-17 Nucleation and crystallization of polymers

Publications (1)

Publication Number Publication Date
AU2001241566A1 true AU2001241566A1 (en) 2001-08-27

Family

ID=24018788

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001241566A Abandoned AU2001241566A1 (en) 2000-02-17 2001-02-17 Nucleation and crystallization of polymers

Country Status (2)

Country Link
AU (1) AU2001241566A1 (en)
WO (1) WO2001061345A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236904B2 (en) 2005-12-28 2012-08-07 Ethicon, Inc. Bioabsorbable polymer compositions exhibiting enhanced crystallization and hydrolysis rates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5553004A (en) * 1993-11-12 1996-09-03 The Board Of Trustees Of The Leland Stanford Jr. University Constrained langevin dynamics method for simulating molecular conformations
US5597457A (en) * 1995-01-23 1997-01-28 The Regents Of The University Of California System and method for forming synthetic protein crystals to determine the conformational structure by crystallography

Also Published As

Publication number Publication date
WO2001061345A1 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2002314466A1 (en) Withasol and methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002362061A1 (en) Preparation of orlistat and orlistat crystalline forms
AU2001281850A1 (en) Use of inulin and inulin derivatives
AU3097500A (en) Crystalline 1alpha-hydroxyvitamin d2 and method of purification thereof
AU4308601A (en) Prevention of ice nucleation by polyglycerol
AU2002346548A1 (en) Regioisomerically pure oxochlorins and methods of synthesis
AU2002211736A1 (en) Methods for synthesizing precipitated silica and use thereof
AU2002317367A1 (en) Predistorting of contention signals
AU2002211370A1 (en) Inhibition of tgf-beta and uses thereof
AU2001275618A1 (en) Novel photochromic polymers and methods of synthesizing same
AU2001269685A1 (en) Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis
AU3553400A (en) Use and production of polypropylene
AU2001288092A1 (en) Method of crystallization
AU3732500A (en) Beclin and uses thereof
AU2002357177A1 (en) Methods of co2-assisted reactive extrusion
AU1919699A (en) Micro-catheters and methods of their manufacture
AU5901100A (en) Micro-electromechanical devices and methods of manufacture
AU5029801A (en) Copolymers of allylphosphonium salts
AU2001241566A1 (en) Nucleation and crystallization of polymers
AU2002304338A1 (en) Highly purified and crystalline form of harringtonine
AU2002322445A1 (en) Crystals and structures of arnb aminotransferases
AU4449100A (en) Novel crystallization products of neotame and methods for producing same
AU2001251651A1 (en) Compositions comprising crystalline condensation polymers and nucleating agents